Case Studies Reveal that Patents Can Hinder Genetic Research and Patient Care

A U.S. District Court judge’s recent decision to invalidate patents on two genes commonly tested to determine risk for breast and ovarian cancers is an important step toward removing legal hurdles that have slowed the development of new genetic testing technology, according to a team of Duke University researchers. [More]


LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.